(PharmaNewsWire.Com, May 25, 2019 ) According to the recent research report the global stable isotope-labelled compounds market is projected to reach USD 294.2 million by 2022 from USD 254.6 million in 2017, at a CAGR of 2.9% during the forecast period.
The stable isotope-labeled compounds market is emerging and fragmented in nature with various regional and international players. In 2016, Cambridge Isotope Laboratories, Inc. (U.S.) and Merck KGaA (Germany) dominated the stable isotope-labeled compounds market.
Cambridge Isotope Laboratories, Inc. specializes in the process of labeling biochemical and organic compounds with highly enriched, stable (non-radioactive) isotopes of carbon, hydrogen, nitrogen, and oxygen. These products find application in structural biology, proteomics, genomics, molecular biology, metabolic research, clinical and diagnostic research, and ultra-trace environmental analysis. To maintain its leading position and increase its customer base in the stable isotope-labeled compounds market, the company mainly focuses on strategic agreements and product launches. Moreover, the company’s isotope separation facility located in Ohio (U.S.) is the world’s largest carbon-13 and oxygen-18 isotope separation facilities and has the only commercial heavy enrichment columns in the world.
Merck KGaA held the second position in the global stable isotope-labeled compounds market in 2016. The company offers stable isotope-labeled compound products through its Life Sciences segment. After the acquisition of Sigma-Aldrich (U.S.) in 2015, the firm became a prominent player in the stable isotope-labeled compounds market. The company offers stable isotope-labeled carbohydrates, amino acids, nucleotides, vitamins among others. Merck KGaA focuses on acquisitions, collaborations, and geographic expansions to strengthen its position in the market. In addition, the presence of a strong distribution and sales network across the globe has enabled this company to maintain its position in the market.
Some of the other players competing in this market are URENCO Limited (U.K.), IsoSciences, LLC (U.S.), Medical Isotopes, Inc. (U.S.), Omicron Biochemicals, Inc. (U.S.), Nordion (Canada) Inc., Trace Sciences International (U.S.), Alsachim (France), Taiyo Nippon Sanso Corporation (Japan), PerkinElmer Inc. (U.S.), and Rotem Industries Israel, Ltd. (Israel).
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
